Skip to main content
Premium Trial:

Request an Annual Quote

Ingenium gets Tissue Archive from GSF

NEW YORK, Feb. 3 - Ingenium Pharmaceuticals has signed an agreement with the GermanNationalResearchCenter for Environment and Health (GSF) to add GSF's tissue archive to its own archive for genotyping, the company said today.

 

This agreement doubles Ingenium's archive, according to the company.

 

Ingenium, of Munich, uses this archive for its Ingenotyping technology, which produces murine models with point mutations in genes for target validation in drug discovery. The company has close ties to GSF. The director of GSF's institute of experimental genetics, Martin Hrabe, is a scientific founder.

 

Hrabe said in a statement that the archive represents "seven years of murine genetic research conducted at the GSF."

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.